WAM
AUPH icon

Worth Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Worth Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,930
Closed -$19K – 459
2022
Q2 		$19K Hold
1,930
– – 0.01% 299
2022
Q1 		$19K Buy
+1,930
New +$29.8K 0.01% 304

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Worth Asset Management's AUPH Position: Q3 2022 in Review

Worth Asset Management sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2022, closing a stake of 1,930 shares — an estimated $19K sold.

Worth Asset Management first reported a position in AUPH in Q1 2022 and held it in 2 quarters. The position peaked at $19K in Q2 2022. 189 funds tracked by Wall St. Rank hold AUPH as of Q3 2022.

  • Worth Asset Management reported no remaining Aurinia Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Worth Asset Management sold 1,930 Aurinia Pharmaceuticals shares in Q3 2022, an estimated $19K.
  • Worth Asset Management first reported a position in Aurinia Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Worth Asset Management's Aurinia Pharmaceuticals position peaked at $19K in Q2 2022.
  • 189 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2022.

Based on Worth Asset Management's 13F filing for Q3 2022, filed 7 Oct 2022.